RecruitingNCT07133113

Medium-term Effects of Treatments in Autoimmune Encephalitis

Studying Autoimmune encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospices Civils de Lyon
Intervention
We aim to assess the clinical response to the treatment initiation protocols most commonly used in autoimmune encephalitis (first-line, first-line with rituximab, dual immunosuppression).(other)
Enrollment
200 enrolled
Eligibility
All sexes
Timeline
2024 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07133113 on ClinicalTrials.gov

Other trials for Autoimmune encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Autoimmune encephalitis →

← Back to all trials